HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
John D Bartlett Selected Research
John D Bartlett Research Topics
Disease
10
Amelogenesis Imperfecta
10/2019 - 12/2002
9
Dental Fluorosis
01/2021 - 06/2005
3
Dental Caries (Decay, Dental)
01/2021 - 09/2012
2
Dental Enamel Hypoplasia
01/2019 - 12/2002
2
Neoplasms (Cancer)
12/2016 - 06/2004
1
Miosis
11/2021
1
Infections
01/2019
1
Uveal melanoma
12/2016
1
Cataract (Cataracts)
01/2016
1
Tooth Diseases
01/2012
1
Odontogenic Tumors (Dental Tissue Neoplasm)
06/2004
1
Dwarfism
01/2003
1
Metabolic Bone Diseases (Osteopenia)
01/2003
1
Craniofacial Abnormalities
01/2003
1
Fibrosarcoma
03/2002
1
Melanoma (Melanoma, Malignant)
03/2002
1
Neoplasm Metastasis (Metastasis)
03/2002
Drug/Important Bio-Agent (IBA)
7
Fluorides
IBA
01/2021 - 09/2008
3
Amelogenin
IBA
09/2014 - 12/2002
3
Proteins (Proteins, Gene)
FDA Link
09/2013 - 06/2008
3
Matrix Metalloproteinase 20
IBA
12/2011 - 12/2002
2
RELT
IBA
10/2019 - 01/2019
2
Sirtuin 1
IBA
12/2015 - 02/2014
1
Brimonidine Tartrate (Alphagan)
FDA Link
Generic
11/2021
1
Trace Elements (Biometals)
IBA
01/2021
1
hydroxide ion
IBA
03/2020
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
01/2019
1
Iodine-125
IBA
12/2016
1
Silicone Oils
IBA
12/2016
1
Sodium Hypochlorite (Clorox)
IBA
09/2014
1
Composite Resins
IBA
09/2014
1
Antioxidants
IBA
08/2014
1
enamel matrix proteins
IBA
08/2014
1
Vitamin E
FDA Link
Generic
08/2014
1
Transcription Factors (Transcription Factor)
IBA
01/2012
1
Collagen Type XVIII (Type XVIII Collagen)
IBA
06/2004
1
Matrix Metalloproteinase 14 (MT1-MMP)
IBA
01/2003
1
Diphosphonates (Bisphosphonates)
IBA
03/2002
1
Alendronate (Alendronate Sodium)
FDA Link
Generic
03/2002
1
Matrix Metalloproteinases (MMPs)
IBA
03/2002
1
Fibronectins (Fibronectin)
IBA
03/2002
1
CTTHWGFTLC peptide
IBA
03/2002
1
matrigel
IBA
03/2002
Therapy/Procedure
1
Brachytherapy
12/2016
1
Vitrectomy
12/2016
1
Lasers (Laser)
01/2016
1
Fluoride Treatment
06/2005